Allogeneic hct - PowerPoint PPT Presentation

Optimizing Timing of Transplant in Hodgkin Lymphoma

Optimizing Timing of Transplant in Hodgkin Lymphoma. Ginna G. Laport, MD Associate Professor of Medicine Division of Blood &amp; Marrow Transplantation Stanford University Medical Center. Hematopoieti c Cell Transplantation in Hodgkin Lymphoma. Prognostic Factors Salvage Regimens

★ ★ ★ ★ ★

419 views • 22 slides

Assessment of Allogeneic HCT in Older Patients with AML and MDS: A CIBMTR Analysis

Assessment of Allogeneic HCT in Older Patients with AML and MDS: A CIBMTR Analysis. McClune B et al. ASCO/ASH Symposium 2009;The Best of ASH Special &amp; Plenary Virtual Presentation. Introduction.

★ ★ ★ ★ ★

204 views • 9 slides

Mohamed L. Sorror , MD, MSc ASH Oral presentation December 2018

Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: A Large Real-Time Multi- Center Prospective Longitudinal Observational Study. Mohamed L. Sorror , MD, MSc

★ ★ ★ ★ ★

87 views • 7 slides

View Allogeneic hct PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Allogeneic hct PowerPoint presentations. You can view or download Allogeneic hct presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.